ICICI Securities recommended reduce rating on Ajanta Pharma with a target price of Rs 2,500 in its research report dated May 01, 2025.
Choice Equity Broking is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 3180 in its research report dated May 02, 2025.
Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 3220 in its research report dated January 30, 2025.
Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 3470 in its research report dated October 28, 2024.
Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 2935 in its research report dated July 30, 2024.
Motilal Oswal is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 2,565 in its research report dated May 02, 2024.
Motilal Oswal is bullish on Ajanta Pharma recommended buy rating on the stock with a target price of Rs 2515 in its research report dated January 31, 2024.
ICICI Securities is bullish on Ajanta Pharma recommended buy rating on the stock with a target price of Rs 1580 in its research report dated July 29, 2023.
Motilal Oswal is bullish on Ajanta Pharma recommended buy rating on the stock with a target price of Rs 1800 in its research report dated July 27, 2023.
YES Securities is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1700 in its research report dated May 08, 2023.
Motilal Oswal is bullish on Ajanta Pharma recommended buy rating on the stock with a target price of Rs 1490 in its research report dated May 06, 2023.
Motilal Oswal is bullish on Ajanta Pharma recommended buy rating on the stock with a target price of Rs 1410 in its research report dated March 10, 2023.
ICICI Direct is bullish on Ajanta Pharmaceuticals recommended buy rating on the stock with a target price of Rs 1385 in its research report dated February 02, 2023.
Motilal Oswal is bullish on Ajanta Pharma recommended buy rating on the stock with a target price of Rs 1410 in its research report dated February 01, 2023.
YES Securities is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 1400 in its research report dated February 02, 2023.
ICICI Direct is bullish on Ajanta Pharmaceuticals recommended buy rating on the stock with a target price of Rs 1505 in its research report dated November 04, 2022.
Motilal Oswal is bullish on Ajanta Pharma recommended buy rating on the stock with a target price of Rs 1560 in its research report dated November 04, 2022.
ICICI Direct is bullish on Ajanta Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1495 in its research report dated July 29, 2022.
ICICI Direct recommended hold rating on Ajanta Pharmaceuticals with a target price of Rs 1305 in its research report dated June 22, 2022.
YES Securities is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 2350 in its research report date May 10, 2022.
ICICI Direct is bullish on Ajanta Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 1955 in its research report dated May 11, 2022.
Motilal Oswal is bullish on Ajanta Pharma recommended buy rating on the stock with a target price of Rs 2080 in its research report dated May 10, 2022.
Ajcon Global is bullish on Ajanta Pharma has recommended buy rating on the stock with a target price of Rs 2400 in its research report dated March 08, 2022.
ICICI Direct is bullish on Ajanta Pharmaceuticals has recommended buy rating on the stock with a target price of Rs 2605 in its research report dated February 02, 2021.
Motilal Oswal is bullish on Ajanta Pharma recommended buy rating on the stock with a target price of Rs 2780 in its research report dated July 30, 2021.